[
  {
    "ts": null,
    "headline": "Janus Henderson Global Life Sciences Fund Q4 2024 Commentary",
    "summary": "The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=10b10afe2a805029d7ce2f9c8b1ec10ce14300270ce9d50ee7971586c5474449",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739392800,
      "headline": "Janus Henderson Global Life Sciences Fund Q4 2024 Commentary",
      "id": 132698753,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1322205585/image_1322205585.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=10b10afe2a805029d7ce2f9c8b1ec10ce14300270ce9d50ee7971586c5474449"
    }
  },
  {
    "ts": null,
    "headline": "IGA: Good Diversification And Fully-Covered Distribution (Rating Upgrade)",
    "summary": "Voya Global Advantage and Premium Opportunity Fund has a 10.74% yield, diversification benefits, and well-covered distributions. Click for my IGA CEF update.",
    "url": "https://finnhub.io/api/news?id=2ba8d05d868d19834abb8a5b6fdaa46772c05175fc15d368f4cc2a0552dcd71b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739377566,
      "headline": "IGA: Good Diversification And Fully-Covered Distribution (Rating Upgrade)",
      "id": 132689669,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1302522750/image_1302522750.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Voya Global Advantage and Premium Opportunity Fund has a 10.74% yield, diversification benefits, and well-covered distributions. Click for my IGA CEF update.",
      "url": "https://finnhub.io/api/news?id=2ba8d05d868d19834abb8a5b6fdaa46772c05175fc15d368f4cc2a0552dcd71b"
    }
  },
  {
    "ts": null,
    "headline": "Amgen, Inc. (AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call Transcript",
    "summary": "Amgen, Inc. (NASDAQ:AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ETCompany ParticipantsNarimon...",
    "url": "https://finnhub.io/api/news?id=89999aebb4fc10324384eedd58042dd814bdec10a29d8ebdf6531db756be1e50",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739373724,
      "headline": "Amgen, Inc. (AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call Transcript",
      "id": 132685933,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Amgen, Inc. (NASDAQ:AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ETCompany ParticipantsNarimon...",
      "url": "https://finnhub.io/api/news?id=89999aebb4fc10324384eedd58042dd814bdec10a29d8ebdf6531db756be1e50"
    }
  }
]